The presence of numerous players has rendered the vendor landscape in the global postpartum hemorrhage (PPH) treatment devices market highly fragmented. As per a recent study by Transparency Market Research (TMR), the market players are currently focusing on innovative public relation campaigns to counter conventional PPH treatment modalities. This however is likely to inflate the operational cost incurred on manufacturing PPH devices, while it is imperative for companies to quote lesser product price to penetrate into emerging markets.
As per TMR, the competition prevailing in the global PPH treatment devices market is likely to intensify in the coming years, as new players make foray. Therefore, with the entry of international players such as Bactiguard AB, 3rd Stone Design, Inc., C. R. Bard, Inc., Cook Medical, Inc., and others, competition is expected to get tougher for the established players.
Overall, the global postpartum hemorrhage treatment devices market is expected to rise at a CAGR of 4.90% between 2015 and 2023. At this pace, the market will reach US$926.1 mn by the end of 2023 from US$604.4 mn in 2014. Regionally, North America held the leading market share of 36.1% in 2014. The consumers in the region enjoy easy access to healthcare. Also the region exhibits availability of advanced medical devices, which are the key factors aiding the market’s expansion in North America.
Among the products available, uterine balloon tamponade constituted the leading segment in 2014. It is easy to use, offers high effectiveness, and is commercially available, which are the chief factors aiding the expansion of the balloon tamponade segment at a CAGR of 4.9% between 2015 and 2023.
Rising Incidence of Postpartum Hemorrhage Fuels Demand for PPH Treatment Devices
The rising prevalence of PPH is the chief factor fuelling the demand for PPH treatment devices around the world. The surge in the number of deaths in women due to complications in pregnancy has compelled government and international organizations to ensure better postpartum medical care. As per the World Bank and United States Agency for International Development (USAID), nearly 99% of maternal deaths are reported from developing nations, where a significantly large section of population cannot afford healthcare.
Companies engaged in PPH treatment devices manufacturing are therefore creating strategies to capitalize on untapped opportunities prevalent across developed nations. This is expected to pave way for the market’s growth in the coming years. “Favorable initiatives by government aimed at making postpartum care more accessible to remote areas and affordable will have positive influence on the overall market,” said a lead TMR analyst.
Lack of Awareness in Developing Nations Emerges as Key Challenge
PPH treatment devices are available in the market for the past two decades. Despite this, a large section of people in developing nations are unaware about the presence of such solutions. This is a key factor limiting the market’s trajectory over the past few years. The impact of lack of awareness is felt more widely in nations across the Middle East and Africa and Asia Pacific.
Also the low acceptance of unconventional PPH treatment devices is creating hindrances for the market. Besides this, the market has continued to reel under the lack of skilled professionals. As a combined effect of these factors, the market may witness decelerated pace of gains for some time.
Nevertheless with companies making effort on improving their distribution channels and promote awareness about PPH treatment devices, it is expected that the market will recover from aforementioned challenges. Through the forecast period, it is expected to exhibit robust growth.
This review is based on information derived from a TMR report, titled “Postpartum Hemorrhage (PPH) Treatment Devices Market (Product - Non-pneumatic Anti-shock Garment (NASG), Uniject Prefilled Injection System, and Uterine Balloon Tamponade (Foley Catheters and Condom Catheters)) - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023.”
The report segments the global postpartum hemorrhage (PPH) treatment devices market as:
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Products
- Non-pneumatic Anti-shock Garment (NASG)
- Uniject Prefilled Injection System
- Uterine Balloon Tamponade
- Foley Catheters
- Condom Catheters
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America (LATAM)
- Middle East & North Africa (MENA)
- Rest of the World
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453